Stay updated on Opregen in Geographic Atrophy Clinical Trial

Sign up to get notified when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Opregen in Geographic Atrophy Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page displays the ClinicalTrials.gov record for Genentech’s OpRegen study in people with geographic atrophy, including its eligibility criteria, recruiting locations, and planned outcomes.
    Difference
    51%
    Check dated 2026-11-09T13:11:24.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now shows release v3.8.0 instead of v3.7.2. The study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T12:36:32.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    A sitewide banner announces NIH website updates and a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T12:37:36.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The footer revision label updates from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T13:28:24.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The footer’s site revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-12T14:11:52.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with a minimal header and footer, indicating access to the study record is blocked; the previous study content and navigation are no longer accessible on this page.
    Difference
    17%
    Check dated 2026-09-21T21:52:38.000Z thumbnail image

Stay in the know with updates to Opregen in Geographic Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Opregen in Geographic Atrophy Clinical Trial page.